India to Colombia: Doxorubicin Export Trade Route

The India to Colombia Doxorubicin corridor is one of India's established pharmaceutical export routes, with 51 shipments documented worth a combined $1.7M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's doxorubicin manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $33.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with doxorubicin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 34.9%, placing it at rank #12 among India's top doxorubicin export destinations globally.

On the import side, key buyers of Indian doxorubicin in Colombia include ALPHARMA S.A.S. , LABORATORIOS LA SANTE S.A., LABORATORIOS LA SANTE S A and 11 others. ALPHARMA S.A.S. is the single largest importer with 16 shipments valued at $344.3K USD.

India's doxorubicin exports to Colombia are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Colombia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, VENUS REMEDIES LIMITED, VENUS REMEDIES LIMITED — together account for 80% of total trade value on this route. The average shipment value of $33.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as doxorubicin 50 mg (doxorubicin hydrochlo and lipodox sun 2mg/ml injection 10ml (doxorubicin hydrochloride liposom injection,2mg/ml, 10ml vials) [1438 pack x 1 vial]vls, suggesting that buyers in Colombia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ALPHARMA S.A.S. is the largest importer with 16 shipments worth $344.3K USD — representing 20% of all doxorubicin imports from India on this route. A total of 14 buyers are active on this corridor.